The article discusses new developed drugs for the treatment of non-insulin dependent diabetes. It was taken into accounts that these newly developed antidiabetic agents include Metformin and Thiazolidinediones, which are both taken orally. Another is exenatide, an injectable long-acting release and incretin-based therapies.